Dr. Strumpf: Interim Dean of School
Dr. Neville E. Strumpf,
the Edith Clemmer Steinbright Professor in Gerontology and Director of the
Center for Gerontologic Nursing Science, has been named interim dean of
the School of Nursing, effective September 1, according to an announcement
on June 7 by President Judith Rodin and Provost Robert Barchi.
"We are delighted that an academician of Dr. Strumpf's stature has
agreed to take on the role of interim dean of the School of Nursing,"
Dr. Rodin said. "Dr. Strumpf's impressive history of combining teaching
with administrative responsibilities and research makes her the ideal candidate
to lead the School through this important transition."
Dr. Strumpf will replace Dr. Norma Lang, the Margaret Bond Simon Dean
and Professor of Nursing, who will step down this summer to devote her time
to teaching and research.
"I am pleased that Dr. Strumpf will apply her considerable talents
to the leadership and stewardship of the School of Nursing," said Dr.
Barchi. Dr. Lang, who will remain as dean through August 31, added that
"leaving the School in such capable hands makes the decision to return
to my own pursuits that much easier."
Dr. Strumpf joined the School of Nursing faculty in 1982 as an assistant
professor. She became director of the Gerontology Nurse Practitioner Program
in 1985, and it has been named first nationally among gerontology programs
in U.S. News & World Report rankings in 1998 and for 2001. She
also was responsible for the implementation of a much-emulated approach
to the integration of gerontology into the undergraduate curriculum.
A leader of long-standing within the School, Dr. Strumpf is known for
her teaching expertise at all levels-- undergraduate, masters and doctoral--as
well as for serving as the School of Nursing's division chair for Adult
Health and Illness from 1993 to 1996.
Dr. Strumpf is a Fellow of the American Academy of Nursing and of the
School of Medicine's Institute on Aging.
Dr. Strumpf is a widely acclaimed researcher, best known for work with
her colleague, Dr. Lois Evans, Viola MacInnes/Independence Professor in
Nursing. Their breakthrough research led to a reduction in the use of restraints
for frail older people in hospitals and nursing homes throughout the nation.
Drs. Strumpf and Evans conducted the only clinical trial funded by the National
Institute on Aging aimed at reducing physical restraints used in nursing
She received (with Dr. Evans and Doris Schwartz) the Maes-MacInnes Award
(1992) for a contribution of singular impact on the nursing profession;
was selected (with Dr. Evans) as the Sigma Theta Tau International Honor
Society in Nursing's Cameo Researcher (1994); and received (with Dr. Evans)
the Sigma Theta Tau International Baxter Foundation Episteme Award (1995),
nursing's most prestigious research recognition.
Dr. Santomero to Federal Reserve Bank
Dr. Anthony M. Santomero, Richard K. Mellon Professor of Finance at the
Wharton School, was appointed on June 29 as Bank President by the Federal
Reserve Bank of Philadelphia. Dr. Santomero began his duties July 10, succeeding
Edward G. Boehne, who retired May 31. The appointment was made by the Bank's
Board of Directors and approved by the Board of Governors of the Federal
Reserve System in Washington, D.C.
Since 1995, Dr. Santomero has served as director of the Wharton Financial
Institutions Center, the world's premier academic research institution on
the financial services industry. He has also been a consultant and advisor
for leading financial institutions and regulatory agencies in the U.S. and
abroad on issues including risk management, financial restructuring, credit
risk evaluation and management, and regulation.
"Tony Santomero has an extensive background in financial services
and monetary policy issues," said Joan Carter, chairman of the Philadelphia
Federal Reserve Bank's board of directors. "I am confident that under
his leadership the Bank will continue to excel as we meet the challenges
of an ever-changing financial environment."
Dr. Santomero, who has requested a leave of absence from the School,
will retain his professorship while serving in his new role.
Dr. Finkel: $1 Million Packard
Dr. Leif Finkel, professor of bioengineering, has received a $1 million
award from the David and Lucile Packard Foundation. Dr. Finkel is a member
of the Institute for Medicine and Engineering (IME). A 1976 graduate of
the University of Maryland, he received a Ph.D. in biophysics from Penn
Over the next five years, the award will support an Interdisciplinary
Science project on "Meso-scale Optical Brain Imaging of Perceptual
The proposal was prepared by Penn faculty from bioengineering, neuroscience,
and physics. Co-PI's are Kwabena Boahen, IME, and assistant professor of
bioengineering; Diego Contreras and Brian Salzberg, neuroscience; and Arjun
Yodh, IME, and professor of physics. Supporting Scientists are George Gerstein
and Larry Palmer from neuroscience.
IHGT's Animal Labs-FDA Letter
Dr. James M. Wilson received a "Warning Letter" from the Food
and Drug Administration on July 3, and he and Institute for Human Gene Therapy
will respond, according to Director of University Communications Ken Wildes.
(The FDA has requested a response in writing in 15 business days.)
Many of the issues raised in the "Warning Letter" were being
addressed at the time of the FDA audit, Mr. Wildes said, and IHGT has made
substantial progress since that time. The toxicology studies, he said, represent
only a small part of the animal model work conducted at IHGT.
Dr. Wilson, IHGT and the University of Pennsylvania continues to take
the FDA's ongoing review very seriously, and IHGT continues to cooperate,
fully and completely, with the agency.
Preventing Diabetic Kidney Failure
Researchers at the School of Medicine have demonstrated in an animal
model that diabetic kidney failure is triggered by a protein that can be
neutralized, thus effectively blocking the development of kidney disease.
Dr. Fuad Ziyadeh is principal investigator of the study and professor
of medicine. "To our knowledge, this is the first proof-of-concept
study to establish that kidney disease in diabetes is caused by this growth-factor
protein. This research addresses both juvenile and adult-onset diabetes,"
explains Dr. Ziyadeh, of the Renal-Electrolyte and Hypertension Division
in HUP. For the complete story click
Almanac, Vol. 47, No. 1, July 18, 2000
| FRONT PAGE | CONTENTS
| RNC at Penn
Rates: 2000-2001 | TALK
ABOUT TEACHING ARCHIVE | BETWEEN
ISSUES | SUMMER at PENN |